This compound is a pharmaceutical intermediate featuring a thiazole ring and a cyano-substituted phenyl ether structure. It is primarily used as a building block in the synthesis of active pharmaceutical ingredients.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 160844-75-7
Febuxostat
pharmaceutical raw material
2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)aniline
pharmaceutical intermediate
1-Acetyl-5-(2-bromopropyl)-2,3-dihydro-1H-indol-7-amine
pharmaceutical intermediate
2-[2-(2,2,2-Trifluoroethoxy)phenoxy]ethyl methanesulfonate
pharmaceutical intermediate
3-Acetyl-5-chlorothiophene-2-sulfonamide
pharmaceutical intermediate
Ethyl 2-(3-formyl-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate
pharmaceutical intermediate
Ethyl 2-(3-cyano-4-hydroxyphenyl)-4-methyl-1,3-thiazole-5-carboxylate
pharmaceutical intermediate
Ethyl 2-(4-hydroxyphenyl)-4-methylthiazole-5-carboxylate
pharmaceutical intermediate
ethyl 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylate
OGAZOYHQFBSRMC-UHFFFAOYSA-N
CCOC(=O)C1=C(N=C(S1)C2=CC(=C(C=C2)OCC(C)C)C#N)C